Teladoc Health Inc Stock Price, News & Analysis

Teladoc Health (NYSE: TDOC) has announced a new collaboration with Amazon to expand access to its chronic condition programs through Amazon's Health Benefits Connector. Eligible customers can now discover and enroll in Teladoc's diabetes, hypertension, pre-diabetes, and weight management programs directly through Amazon's platform.

Teladoc currently has over 1 million active enrollees in its chronic condition programs, which combine connected devices, data-driven personalization, and expert coaching to promote better cardiometabolic health. The partnership aims to address the challenge of enrollment barriers, noting that nearly 25% of U.S. adults are unaware of their available health plan benefits.

The collaboration focuses on improving healthcare accessibility and simplifying the enrollment process, with both companies planning to explore additional opportunities to enhance consumer healthcare experiences.

Teladoc Health (NYSE: TDOC), the global leader in virtual care, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company will be represented by CEO Chuck Divita and CFO Mala Murthy at the event in San Francisco on January 13, 2025, at 4:30 p.m. PT (7:30 p.m. ET).

Interested parties can access a live audio webcast of the presentation, and a replay will be made available through the company's investor relations website at ir.teladochealth.com/news-and-events/events-and-presentations.

Teladoc Health (NYSE: TDOC) has launched enhanced AI capabilities for its Virtual Sitter solution to improve patient safety in hospitals. The new technology enables a single remote staff member to monitor up to 25% more patients, addressing the critical issue of hospital falls, which affect nearly 1 million patients annually and cost approximately $50 billion in medical expenses. The AI-enabled system uses advanced algorithms, motion detection, and pose estimation to detect potentially dangerous patient movements, allowing faster intervention. The solution runs on Teladoc's TV Pro devices using local processing for enhanced security and performance.

Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, announced its participation in the 36th Annual Piper Sandler Healthcare Conference. The event will take place in New York on Tuesday, December 3, 2024, at 12:30 p.m. ET. CEO Chuck Divita and CFO Mala Murthy will represent the company. A live audio webcast and replay of the presentation will be accessible through Teladoc's investor relations website.

Teladoc Health (NYSE:TDOC) has granted inducement awards to two new non-executive employees, effective November 1, 2024. The awards consist of restricted stock units covering 70,575 shares of common stock. The vesting schedule includes one-third of shares on the first anniversary, with the remaining shares vesting quarterly over the following two years. These awards were approved by the Compensation Committee under the 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.

Teladoc Health (TDOC) reported Q3 2024 financial results with revenue of $640.5 million, down 3% year-over-year. The company posted a net loss of $33.3 million, or $0.19 per share, improving from a $57.1 million loss in Q3 2023. Integrated Care segment revenue grew 2% to $383.7 million, while BetterHelp segment declined 10% to $256.8 million. Adjusted EBITDA decreased 6% to $83.3 million. International revenue showed strength with 15% growth to $104.3 million, while U.S. revenue declined 6% to $536.2 million.

Teladoc Health Inc. (NYSE: TDOC), the global leader in whole-person virtual care, has announced the release date for its third quarter 2024 financial results. The results will be disclosed on Wednesday, October 30, 2024, after the market closes. Following the release, the company will host a conference call at 4:30 p.m. E.T. to review the results.

Participants can join the conference call by dialing 1-833-470-1428 (U.S.) and using the access code # 781291. International participants can find global dial-in numbers at a provided link. A live audio webcast will be available at the Teladoc Health investor relations website. A replay of the call will be accessible via webcast shortly after completion and remain available for approximately 90 days.

Teladoc Health (NYSE:TDOC), the global leader in whole-person virtual care, has announced the issuance of inducement awards to three new non-executive employees. Effective October 1, 2024, these employees were granted awards of restricted stock units covering a total of 105,000 shares of Teladoc Health's common stock. The vesting schedule for these units is as follows:

• One-third of the underlying shares vest on the first anniversary of the grant date
• The remaining shares vest quarterly over the subsequent two years

These awards were approved by the Compensation Committee of Teladoc Health's Board of Directors and were granted under the company's 2023 Employment Inducement Incentive Award Plan, in compliance with New York Stock Exchange Rule 303A.08.

Teladoc Health (NYSE:TDOC), a leader in virtual care, has announced an inducement award for a new employee. Terre Layton, joining as Senior Vice President of Product for BetterHelp, received 50,000 restricted stock units of Teladoc Health's common stock on September 1, 2024. The vesting schedule is structured as follows:

• One-third of the shares vest on the first anniversary of the grant date
• The remaining two-thirds vest quarterly over the subsequent two years

This award, approved by the Compensation Committee of Teladoc's Board of Directors, was granted under the company's 2023 Employment Inducement Incentive Award Plan, in compliance with NYSE Rule 303A.08.